AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

This common problem is called solar purpura, and it is largely the sun causing the damage to the skin, thinning it with age.

ANSWER: This common problem is called solar purpura, and it is largely the sun causing the damage to the skin, thinning it ...

This common problem is called solar purpura, and it is largely the sun causing the damage to the skin, thinning it with age.

I thought you could help with a stubborn problem. I am a healthy and active 78-year-old woman who, I admit, likes to look younger than my age. The problem is my skin, especially on my hands and arms; ...

I thought you could help with a stubborn problem. I am a healthy and active 78-year-old woman who, I admit, likes to look ...

The biopharmaceutical industry is positioned for continued recovery, driven by recent FDA approvals and billion-dollar ...

Sanofi and Regeneron's fully human monoclonal antibody Dupixent (dupilumab) has gained approval from the US Food and Drug ...

Aclaris Therapeutics, Inc.’s ACRS share price has surged by 6.72%, which has investors questioning if this is right time to sell.

Insmed invests heavily in a robust pipeline with multi-billion potential, positioning for future growth. Check out why INSM ...

Often harmless, sometimes a sign of illness: what causes halitosis and what can you do to keep your breath fresh?

The FDA has approved the popular drug Dupixent (generic name, dupilumab) for adults and kids 12 and up with chronic spontaneous urticaria (CSU), a long-lasting itchy skin condition, when regular ...